What is the connection between estrogen and breast cancer?
The connection between estrogen and breast cancer is that estrogen is considered to be an initiator of cancer or promoter of gynecological cancer, including breast cancer. In addition, correlation of estrogen and breast cancer has been known for years, which has caused many women to interrupt or reject hormone substitution therapy. Hormone substitution therapy is often given to women to alleviate the effects of menopause, including a flash of hot flashes, night sweat and vaginal dryness. In addition, it is assumed that hormone substitution therapy reduces mood fluctuations, prevents osteoporosis and contributes to a healthy heart.
In women who have a family or personal history of gynecological cancer, such as uterine or breast cancer, alternative treatment of menopause symptoms are recommended. Estrogen levels may fluctuate wildly when hormonal therapy arrival, which may be a risk factor in cancer obtaining. Other things that may affect estrogen levels include consumption of soy productand obese.
As menopause approaches, estrogen levels fluctuate and then fall. This causes classic menopausal symptoms that often make women look for relief from their doctors. However, many doctors encourage women to seek alternative remedies to alleviate their symptoms, especially if the symptoms are mild.
Because the connection between estrogen and breast cancer is so strong, unless it is debilitating and does not respond to other therapeutic methods, the use of hormonal therapy should be discouraged. This is especially important for women who have a family history of breast cancer positive to estrogen or women who had disease. Thanks to this type of breast cancer, women are more susceptible to the effects of estrogen, unlike the estrogen receptor of the negative types of breast cancer. Alternative methods of menopausal symptom include herbal remedies and fluid supplementation.
korElaiation between estrogen and breast cancer is particularly important for women who wish to take hormones for a longer period of time. When the risk is negligible for a short time, they are generally negligible. The risk of breast cancer is becoming more important that the longer woman continues to receive hormone substitution therapy. The use of estrogen itself, in the absence of progesterone, can dramatically increase the risk of a woman for cancer of endometrium or uterus. However, a combination of estrogen progesterone can significantly reduce the risk.
doctors must advise their patients on alternative treatment methods for menopausal symptoms and explain the risk and binding between estrogen and breast cancer. In addition, it is a reassuring woman that menopausal symptoms are only temporary, they can often encourage them to use alternative and safer treatment methods. When women decide that hormone substitution therapy is true to them, it needs to provide subsequent care and offer screening tests such as mammograms, pelvic examsand parcel paints.